Authors: Schnog, JB Duits, AJ

Citation: Jb. Schnog et Aj. Duits, Untitled - Reply, CLIN IMMUNO, 98(3), 2001, pp. 384-384

Authors: Schnog, JB van der Dijs, FPL Fokkema, MR Muskiet, FD Muskiet, FAJ

Citation: Jb. Schnog et al., Folate status assessment and folic acid supplements in sickle cell disease, J PED H ONC, 23(8), 2001, pp. 548-548

Authors: Schnog, JB Kater, AP Mac Gillavry, MR Duits, AJ Lard, LR van der Dijs, FPL Brandjes, DPM ten Cate, H van Eps, LWS Rojer, RA

Citation: Jb. Schnog et al., Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study, AM J HEMAT, 68(3), 2001, pp. 179-183

Authors: Schnog, JB Keli, SO Pieters, RA Rojer, RA Duits, AJ

Citation: Jb. Schnog et al., Duffy phenotype does not influence the clinical severity of sickle cell disease, CLIN IMMUNO, 96(3), 2000, pp. 264-268

Authors: Schnog, JB van der Dijs, FPL Brouwer, DAJ Duits, AJ Muskiet, FD Muskiet, FAJ

Citation: Jb. Schnog et al., Plasma homocysteine levels in sickle cell disease and the need for folate supplementation, J PED H ONC, 22(2), 2000, pp. 184-185

Authors: Duits, AJ Schnog, JB Lard, LR Saleh, AW Rojer, RA

Citation: Aj. Duits et al., Elevated IL-8 levels during sickle cell crisis, EUR J HAEMA, 61(5), 1998, pp. 302-305